Ashwini Esnakula
Overview
Explore the profile of Ashwini Esnakula including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haight P, Bilbe C, Riedinger C, Backes F, Bixel K, Chambers L, et al.
Gynecol Oncol
. 2025 Feb;
194:80-85.
PMID: 39970634
Background: Sentinel lymph node (SLN) mapping has become standard-of-care in endometrial cancer surgical staging. While removal of "enlarged" lymph nodes is recommended regardless of SLN mapping, there is no data...
2.
Haight P, Esnakula A, Riedinger C, Suarez A, Gillespie J, Patton A, et al.
NPJ Precis Oncol
. 2025 Feb;
9(1):41.
PMID: 39922938
We performed molecular analysis of a single-institution cohort of clinically diagnosed mixed-histology endometrial carcinoma (MEC). A gynecologic pathologist confirmed that 72 cases met diagnostic criteria for MEC based on WHO...
3.
Haight P, Lammers S, Kistenfeger Q, Leipold C, Suarez A, Tozbikian G, et al.
Gynecol Oncol
. 2024 Oct;
191:194-200.
PMID: 39442372
Objectives: The American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) recommend cold ischemia time (cIT) be <60 min, and formalin fixation time (FFT) 6-72 h, to optimize immunohistochemistry...
4.
Manne A, Esnakula A, Sheel A, Sara A, Manne U, Paluri R, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201728
Neoadjuvant therapy (NAT) for early-stage pancreatic ductal adenocarcinoma (PDA) has recently gained prominence. We investigated the clinical significance of mucin 5 AC (MUC5AC), which exists in two major glycoforms, a...
5.
Riedinger C, Eisele C, Esnakula A, Stover D, Freud A, Cosgrove C
Front Immunol
. 2024 Jul;
15:1422342.
PMID: 39076998
Invasive lobular breast cancer (ILC) is characterized by a relatively high risk for late recurrence and a unique metastatic pattern with an increased risk for metastasis to gynecologic organs and...
6.
Brown M, Haight P, Ringel M, Phay J, Esnakula A, Vazzano J, et al.
Gynecol Oncol Rep
. 2024 Jul;
54:101456.
PMID: 39076679
Malignant struma ovarii is an exceedingly rare pathology with a paucity of established criteria regarding management and surveillance with recommendations largely based on case reports and retrospective data. Many authors...
7.
Oladeru O, Rajack F, Esnakula A, Naab T, Kanaan Y, Ricks-Santi L
Biomedicines
. 2024 Jul;
12(7).
PMID: 39062096
Quadruple-negative breast cancer (QNBC) is a triple-negative breast cancer (TNBC) subtype that lacks expression of the androgen (AR) receptor. Few studies have focused on this highly aggressive breast cancer, portending...
8.
Hammer P, Toland A, Shaheen M, Shenoy A, Esnakula A, Hicks M, et al.
Arch Pathol Lab Med
. 2024 Mar;
148(11):e374-e385.
PMID: 38547914
Context.—: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors of uncertain histogenesis expressing smooth muscle and melanocytic markers. The clinicopathologic spectrum in young patients is not well documented. Objective.—:...
9.
Shaker N, Shen R, Limbach A, Satturwar S, Kobalka P, Ahmadian S, et al.
J Am Soc Cytopathol
. 2024 Mar;
13(3):205-212.
PMID: 38433072
Introduction: Accurate grading of pancreatic neuroendocrine tumors (PanNETs) relies on the assessment of Ki-67 immunohistochemistry (IHC). While digital imaging analysis (DIA) has been employed for Ki-67 IHC assessment in surgical...
10.
Riedinger C, Esnakula A, Haight P, Suarez A, Chen W, Gillespie J, et al.
Cancer
. 2024 Mar;
130(9):1713-1714.
PMID: 38430468
No abstract available.